Julie Khlevner, MD: Linaclotide for Pediatric Functional Con

We sat down with Julie Khlevner, MD, to discuss new efficacy endpoint data from the phase 3 study used to support the FDA approval of linaclotide for pediatric functional constipation.

Related Keywords

Rome , Lazio , Italy , Julie Khlevner , Drug Administration , Lancet Gastroenterology , Pediatric Gastrointestinal Motility Center , Columbia University Medical Center , Bristol Stool Form Scale , Reinforces Safety , Pediatric Functional , Functional Constipation , Linaclotide , Linzess , Irritable Bowel Syndrome , Ribs , Spontaneous Bowel Movement ,